Related references
Note: Only part of the references are listed.Are Randomized Controlled Trials on Pharmacotherapy and Psychotherapy for Positive Symptoms of Schizophrenia Comparable? A Systematic Review of Patient and Study Characteristics
Irene Bighelli et al.
SCHIZOPHRENIA BULLETIN (2020)
Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study
Yusuke Iwata et al.
BIOLOGICAL PSYCHIATRY (2019)
Clozapine augmentation strategies - a systematic meta-review of available evidence. Treatment options for clozapine resistance
Elias Wagner et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Continuation Electroconvulsive Therapy for Patients With Clozapine-Resistant Schizophrenia A Pilot Study
Raphael J. Braga et al.
JOURNAL OF ECT (2019)
Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, Added to Clozapine for the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
Chieh-Hsin Lin et al.
BIOLOGICAL PSYCHIATRY (2018)
Quality of randomized controlled trials of new generation antidepressants and antipsychotics identified in the China National Knowledge Infrastructure (CNKI): a literature and telephone interview study
Zheng Tong et al.
BMC MEDICAL RESEARCH METHODOLOGY (2018)
ECT augmentation of clozapine for clozapine-resistant schizophrenia: A meta-analysis of randomized controlled trials
Gang Wang et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2018)
Effects of adjunctive fluvoxamine on metabolic parameters and psychopathology in clozapine-treated patients with schizophrenia: A 12-week, randomized, double-blind, placebo-controlled study
Mong-Liang Lu et al.
SCHIZOPHRENIA RESEARCH (2018)
Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial
Anthony P. Morrison et al.
LANCET PSYCHIATRY (2018)
The Societal Cost of Schizophrenia: A Systematic Review
Huajie Jin et al.
PHARMACOECONOMICS (2017)
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness
Thomas RE Barnes et al.
HEALTH TECHNOLOGY ASSESSMENT (2017)
Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors
A. Demjaha et al.
PSYCHOLOGICAL MEDICINE (2017)
Efficacy of electroconvulsive therapy augmentation for partial response to clozapine: a pilot randomized ECT - sham controlled trial
Debora Luciana Melzer-Ribeiro et al.
ARCHIVES OF CLINICAL PSYCHIATRY (2017)
Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia Systematic Overview and Quality Appraisal of the Meta-analytic Evidence
Christoph U. Correll et al.
JAMA PSYCHIATRY (2017)
Efficacy of electroconvulsive therapy augmentation for partial response to clozapine: a pilot randomized ECT - sham controlled trial
Debora Luciana Melzer-Ribeiro et al.
ARCHIVES OF CLINICAL PSYCHIATRY (2017)
Clozapine Response Rates among People with Treatment-Resistant Schizophrenia: Data from a Systematic Review and Meta-Analysis
Dan Siskind et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2017)
Guidelines for the Pharmacotherapy of Schizophrenia in Adults
Gary Remington et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2017)
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
Oliver D. Howes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Clozapine V. first-and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis
Dan Siskind et al.
BRITISH JOURNAL OF PSYCHIATRY (2016)
Memantine augmentation in clozapine-refractory schizophrenia: a randomized, double-blind, placebo-controlled crossover study
S. R. T. Veerman et al.
PSYCHOLOGICAL MEDICINE (2016)
Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: A systematic review and meta-analysis
John Lally et al.
SCHIZOPHRENIA RESEARCH (2016)
Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia A Network Meta-analysis
Myrto T. Samara et al.
JAMA PSYCHIATRY (2016)
Efficacy and safety of combining clozapine with electrical or magnetic brain stimulation in treatment-refractory schizophrenia
Shyam Sundar Arumugham et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2016)
Electroconvulsive Therapy Augmentation in Clozapine-Resistant Schizophrenia: A Prospective, Randomized Study
Georgios Petrides et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Glutamatergic Neurometabolites in Clozapine-Responsive and -Resistant Schizophrenia
Meghan Elizabeth Goldstein et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms
Deanna L. Kelly et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2015)
Reboxetine Adjuvant Therapy in Patients With Schizophrenia Showing a Suboptimal Response to Clozapine A 12-Week, Open-Label, Pilot Study
Antonio Bruno et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2014)
Augmentation of Clozapine With Ziprasidone in Refractory Schizophrenia A Double-Blind, Placebo-Controlled Study
Maria Rosaria A. Muscatello et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2014)
Augmentation of Clozapine With Agomelatine in Partial-Responder Schizophrenia A 16-Week, Open-Label, Uncontrolled Pilot Study
Antonio Bruno et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2014)
Equipercentile linking of the BPRS and the PANSS
S. Leucht et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
Lamotrigine augmentation in patients with schizophrenia who show partial response to clozapine treatment
Sefa Vayisoglu et al.
SCHIZOPHRENIA RESEARCH (2013)
Augmenting Clozapine With Sertindole A Double-Blind, Randomized, Placebo-Controlled Study
Jimmi Nielsen et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
Alkomiet Hasan et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2012)
Antipsychotic polypharmacy in clozapine resistant schizophrenia: a randomized controlled trial of tapering antipsychotic co-treatment
Eila Repo-Tiihonen et al.
MENTAL ILLNESS (2012)
Duloxetine as adjunctive treatment to clozapine in patients with schizophrenia: a randomized, placebo-controlled trial
Umberto Mico et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2011)
Aripiprazole Versus Haloperidol in Combination With Clozapine for Treatment-Resistant Schizophrenia in Routine Clinical Care A Randomized, Controlled Trial
Corrado Barbui et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study
M. R. A. Muscatello et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Pimozide Augmentation of Clozapine Inpatients with Schizophrenia and Schizoaffective Disorder Unresponsive to Clozapine Monotherapy
Joseph I. Friedman et al.
NEUROPSYCHOPHARMACOLOGY (2011)
A pilot double-blind sham-controlled trial of repetitive transcranial magnetic stimulation for patients with refractory schizophrenia treated with clozapine
Danilo Rocha de Jesus et al.
PSYCHIATRY RESEARCH (2011)
Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study
Maria Rosaria A. Muscatello et al.
SCHIZOPHRENIA RESEARCH (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial
W. Wolfgang Fleischhacker et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Topiramate Augmentation in Clozapine-Treated Patients With Schizophrenia Clinical and Metabolic Effects
Margaret K. Hahn et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2010)
Adjunctive Risperidone for Partially Responsive People with Schizophrenia Treated with Clozapine
Elaine Weiner et al.
NEUROPSYCHOPHARMACOLOGY (2010)
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009
Julie Kreyenbuhl et al.
SCHIZOPHRENIA BULLETIN (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Modafinil for Clozapine-Treated Schizophrenia Patients: A Double-Blind, Placebo-Controlled Pilot Trial
Oliver Freudenreich et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial
H. Afshar et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial
M. Zink et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
A placebo-controlled study of extract of ginkgo biloba added to clozapine in patients with treatment-resistant schizophrenia
Ali Doruk et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2008)
Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: An 8-week, randomized, double-blind, placebo-controlled trial
Jae Seung Chang et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial
H. -J. Assion et al.
PHARMACOPSYCHIATRY (2008)
Add-on mirtazapine enhances effects on cognition in schizophrenic patients under stabilized treatment with clozapine
Roberto Delle Chiaie et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2007)
Effects of repetitive Transcranial magnetic stimulation on auditory hallucinations refractory to clozapine
Marina O. Rosa et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients:: A double-blind, placebo-controlled study
R. Zoccali et al.
SCHIZOPHRENIA RESEARCH (2007)
Risperidone augmentation for schizophrenia partially responsive to clozapine: A double-blind, placebo-controlled trial
Oliver Freudenreich et al.
SCHIZOPHRENIA RESEARCH (2007)
Aripiprazole augmentation in the management of residual symptoms in clozapine-treated outpatients with chronic schizophrenia: An open-label pilot study
Charalampos I. Mitsonis et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: Experience in a multistate Medicaid population, 1998-2003
Elaine H. Morrato et al.
CLINICAL THERAPEUTICS (2007)
Comparison of clozapine-amisulpride and clozapine-quetiapine combinations for patients with schizophrenia who are partially responsive to clozapine: A single-blind randomized study
Yasin Genc et al.
ADVANCES IN THERAPY (2007)
Glycine transporter I inhibitor, N-methylglycine (Sarcosine), added to clozapine for the treatment of schizophrenia
Hsien-Yuan Lane et al.
BIOLOGICAL PSYCHIATRY (2006)
Clozapine alone versus clozapine and risperidone with refractory schizophrenia
WG Honer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia
DC Henderson et al.
ACTA PSYCHIATRICA SCANDINAVICA (2006)
Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia
F Mouaffak et al.
CLINICAL NEUROPHARMACOLOGY (2006)
Aripiprazole augmentation of clozapine in treatment-resistant schizophrenia - A clinical observation
M Ziegenbein et al.
CLINICAL DRUG INVESTIGATION (2006)
Addition of lamotrigine to clozapine in inpatients with chronic psychosis
AH Heck et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Double-blind, placebo-controlled, crossover trial of clozapine plus glycine in refractory schizophrenia negative results
P Diaz et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
Combination of clozapine and ziprasidone in treatment-resistant schizophrenia - An open clinical study
M Ziegenbein et al.
CLINICAL NEUROPHARMACOLOGY (2005)
A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: Efficacy and safety
AEA Yagcioglu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Clozapine augmented with risperidone in the treatment of schizophrenia: A randomized, double-blind, placebo-controlled trial
RC Josiassen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
The effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled study
R Zoccali et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2004)
Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross-over study
R Stryjer et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2004)
Electroconvulsive therapy for the treatment of dozapine nonresponders suffering from schizophrenia - An open label study
KH Kho et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2004)
Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine
J Munro et al.
ACTA PSYCHIATRICA SCANDINAVICA (2004)
Lamotrigine in treatment-resistant schizophrenia: A randomized placebo-controlled crossover trial
J Tiihonen et al.
BIOLOGICAL PSYCHIATRY (2003)
Efficacy of electroconvulsive therapy combined with antipsychotic medication in treatment-resistant schizophrenia: A prospective, open trial
WK Tang et al.
JOURNAL OF ECT (2002)
A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia
DC Goff et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
An open trial of risperidone augmentation of partial response to clozapine
CG Taylor et al.
SCHIZOPHRENIA RESEARCH (2001)
Addition of risperidone to clozapine therapy in chronically psychotic inpatients
IW de Groot et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
Placebo-controlled trial of glycine added to clozapine in schizophrenia
AE Evins et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Share Paper
